Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 92
12
Diseases
227
Unique genes
0.033
Avg. similarity score
Spinocerebellar ataxia
Most-connected disease (9 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Spinocerebellar ataxia
Cerebellar ataxia
Spastic ataxia
spinocerebellar ataxia type 42
autosomal recessive cerebellar ataxia
spinocerebellar ataxia, autosomal recessive 23
3m syndrome
Cayman type cerebellar ataxia
Spastic ataxia optic atrophy dysarthria syndrome
spinocerebellar ataxia type 13
spinocerebellar ataxia, autosomal recessive 27
spinocerebellar ataxia, autosomal recessive 28
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Spinocerebellar ataxia | 9 | 9 | 104 |
| Cerebellar ataxia | 6 | 6 | 114 |
| Spastic ataxia | 4 | 4 | 70 |
| spinocerebellar ataxia type 42 | 3 | 3 | 1 |
| autosomal recessive cerebellar ataxia | 2 | 2 | 1 |
| spinocerebellar ataxia, autosomal recessive 23 | 2 | 2 | 1 |
| 3m syndrome | 1 | 1 | 3 |
| Cayman type cerebellar ataxia | 1 | 1 | 1 |
| Spastic ataxia optic atrophy dysarthria syndrome | 1 | 1 | 1 |
| spinocerebellar ataxia type 13 | 1 | 1 | 1 |
| spinocerebellar ataxia, autosomal recessive 27 | 1 | 1 | 1 |
| spinocerebellar ataxia, autosomal recessive 28 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CACNA1G | 4 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia, spinocerebellar ataxia type 42 |
| AFG3L2 | 3 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia |
| CACNA1A | 3 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia |
| CWF19L1 | 3 / 12 | autosomal recessive cerebellar ataxia, Cerebellar ataxia, Spinocerebellar ataxia |
| ITPR1 | 3 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia |
| SETX | 3 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia |
| SYNE1 | 3 / 12 | Cerebellar ataxia, Spastic ataxia, Spinocerebellar ataxia |
| TDP2 | 3 / 12 | Cerebellar ataxia, Spinocerebellar ataxia, spinocerebellar ataxia, autosomal recessive 23 |
| ANO10 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| ATCAY | 2 / 12 | Cayman type cerebellar ataxia, Cerebellar ataxia |
| CA8 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| CCDC8 | 2 / 12 | 3m syndrome, Spinocerebellar ataxia |
| CCDC88C | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| COQ4 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| COQ8A | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| COX3 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| DAB1 | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| DNMT1 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| ELOVL4 | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| ERCC4 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| ESR1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| FAT2 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| FGF14 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| FLNC | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| GDAP2 | 2 / 12 | Spinocerebellar ataxia, spinocerebellar ataxia, autosomal recessive 27 |
| GRM1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| HARS1 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| JMJD8 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| KCNC3 | 2 / 12 | Spinocerebellar ataxia, spinocerebellar ataxia type 13 |
| KIF1C | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| MTPAP | 2 / 12 | Spastic ataxia, Spastic ataxia optic atrophy dysarthria syndrome |
| NOP56 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| NPTX1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PDYN | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PEX6 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PIK3R5 | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| PITRM1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PLA2G6 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| PMPCA | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PNPLA6 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| POLG | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| POLR3A | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| PRDX3 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PRKCG | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| PUM1 | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| RHBDL1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| RUBCN | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| SCN8A | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| SEPSECS | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| SLC36A1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| SNX14 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| SPTBN2 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| STUB1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| STXBP1 | 2 / 12 | Cerebellar ataxia, Spastic ataxia |
| SYT14 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| TDP1 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| THG1L | 2 / 12 | Spinocerebellar ataxia, spinocerebellar ataxia, autosomal recessive 28 |
| TTBK2 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| TUBB6 | 2 / 12 | Spastic ataxia, Spinocerebellar ataxia |
| VPS13D | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| VPS41 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| WDR24 | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
| WWOX | 2 / 12 | Cerebellar ataxia, Spinocerebellar ataxia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Spinocerebellar ataxia | KEGG | 23 / 144 | 8.5× | 2.66e-15 | 9.40e-13 ✓ sig. |
| Pathways of neurodegeneration - multiple diseases | KEGG | 30 / 480 | 3.3× | 7.45e-9 | 6.77e-7 ✓ sig. |
| Parkinson disease | KEGG | 19 / 268 | 3.8× | 7.67e-7 | 3.87e-5 ✓ sig. |
| Oxidative phosphorylation | KEGG | 13 / 137 | 5.0× | 1.88e-6 | 8.34e-5 ✓ sig. |
| Prion disease | KEGG | 18 / 275 | 3.5× | 4.70e-6 | 1.81e-4 ✓ sig. |
| Huntington disease | KEGG | 19 / 308 | 3.3× | 6.02e-6 | 2.20e-4 ✓ sig. |
| Respiratory electron transport | Reactome | 9 / 83 | 5.7× | 2.56e-5 | 7.30e-4 ✓ sig. |
| Diabetic cardiomyopathy | KEGG | 14 / 205 | 3.6× | 3.45e-5 | 9.41e-4 ✓ sig. |
| Amyotrophic lateral sclerosis | KEGG | 19 / 368 | 2.7× | 7.13e-5 | 1.70e-3 ✓ sig. |
| Anchoring of the basal body to the plasma membrane | Reactome | 9 / 98 | 4.9× | 9.61e-5 | 2.18e-3 ✓ sig. |
| Chemical carcinogenesis - reactive oxygen species | KEGG | 14 / 227 | 3.3× | 1.04e-4 | 2.33e-3 ✓ sig. |
| Retrograde endocannabinoid signaling | KEGG | 11 / 149 | 3.9× | 1.21e-4 | 2.61e-3 ✓ sig. |
| Alzheimer disease | KEGG | 19 / 388 | 2.6× | 1.43e-4 | 2.99e-3 ✓ sig. |
| Thermogenesis | KEGG | 13 / 234 | 2.9× | 5.07e-4 | 8.04e-3 ✓ sig. |
| Hedgehog 'off' state | Reactome | 6 / 56 | 5.7× | 6.29e-4 | 9.55e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| proton transmembrane transport | GO:1902600 | 14 / 181 | 6.4× | 4.72e-8 | 6.48e-6 ✓ sig. |
| proton motive force-driven mitochondrial ATP synthesis | GO:0042776 | 9 / 64 | 11.6× | 7.58e-8 | 9.53e-6 ✓ sig. |
| aerobic respiration | GO:0009060 | 9 / 68 | 10.9× | 1.30e-7 | 1.50e-5 ✓ sig. |
| ATP synthesis coupled electron transport | GO:0042773 | 4 / 7 | 47.0× | 7.21e-7 | 6.38e-5 ✓ sig. |
| monoatomic ion transmembrane transport | GO:0034220 | 18 / 404 | 3.7× | 2.36e-6 | 1.64e-4 ✓ sig. |
| respiratory chain complex IV assembly | GO:0008535 | 4 / 9 | 36.6× | 2.55e-6 | 1.74e-4 ✓ sig. |
| mitochondrion organization | GO:0007005 | 10 / 130 | 6.3× | 4.29e-6 | 2.65e-4 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 23 / 667 | 2.8× | 7.10e-6 | 3.97e-4 ✓ sig. |
| glycosphingolipid catabolic process | GO:0046479 | 4 / 12 | 27.4× | 9.72e-6 | 5.11e-4 ✓ sig. |
| regulation of SNARE complex assembly | GO:0035542 | 4 / 12 | 27.4× | 9.72e-6 | 5.11e-4 ✓ sig. |
| mitochondrial electron transport, NADH to ubiquinone | GO:0006120 | 6 / 47 | 10.5× | 2.13e-5 | 9.45e-4 ✓ sig. |
| protein catabolic process | GO:0030163 | 8 / 97 | 6.8× | 2.39e-5 | 1.03e-3 ✓ sig. |
| regulation of autophagy | GO:0010506 | 7 / 73 | 7.9× | 2.94e-5 | 1.20e-3 ✓ sig. |
| action potential | GO:0001508 | 6 / 53 | 9.3× | 4.29e-5 | 1.61e-3 ✓ sig. |
| chaperone-mediated autophagy | GO:0061684 | 3 / 7 | 35.3× | 5.97e-5 | 2.05e-3 ✓ sig. |